Mingfeng Han
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 1%
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 11
- SARS-CoV-2 and COVID-19 Research 9
- SARS-CoV-2 detection and testing 3
-
- Long-Term Effects of COVID-19 5
- Co-authors
- Xiuyong Li (7 shared papers)Wei Sun (2 shared papers)Haiming Wei (1 shared paper)Xiaohu Zheng (1 shared paper)Aijun Pan (1 shared paper)Binqing Fu (1 shared paper)Tiantian Li (1 shared paper)Yun Yang (1 shared paper)
- Journals
- Frontiers in Medicine (3 papers)Aging (2 papers)Journal of Inflammation Research (2 papers)Frontiers in Pharmacology (1 paper)International Immunopharmacology (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Mingfeng Han
25 papers receiving 3.8k citations
Mingfeng Han's Hit Papers
Peers
Comparison fields: 5 of 142
- Infectious Diseases 2.2k
- Neurology 1.1k
- Clinical Psychology 517
- Pharmacology 144
- Obstetrics and Gynecology 110
Countries citing papers authored by Mingfeng Han
This map shows the geographic impact of Mingfeng Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfeng Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfeng Han more than expected).
Fields of papers citing papers by Mingfeng Han
This network shows the impact of papers produced by Mingfeng Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfeng Han. The network helps show where Mingfeng Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingfeng Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effective treatment of severe COVID-19 patients with tocilizumab Hit paper breakdown → | 2020 | 1904 |
| 2 | Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19 Hit paper breakdown → | 2020 | 753 |
| 3 | [Mental health survey of medical staff in a tertiary infectious disease hospital for COVID-19]. Hit paper breakdown → | 2020 | 514 |
| 4 | Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial Hit paper breakdown → | 2020 | 349 |
| 5 | 2020 | 170 | |
| 6 | 2021 | 33 | |
| 7 | 2020 | 25 | |
| 8 | 2018 | 21 | |
| 9 | 2020 | 20 | |
| 10 | 2020 | 19 | |
| 11 | 2020 | 15 | |
| 12 | 2020 | 15 | |
| 13 | 2022 | 14 | |
| 14 | 2023 | 6 | |
| 15 | 2025 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2020 | 5 | |
| 18 | 2025 | 4 | |
| 19 | 2021 | 3 | |
| 20 | 2024 | 2 |
About Mingfeng Han
Mingfeng Han is a scholar working on Infectious Diseases, Neurology, Surgery, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 3.9k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (11 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Long-Term Effects of COVID-19 (5 papers), SARS-CoV-2 detection and testing (3 papers), COVID-19 diagnosis using AI (2 papers), Whipple's Disease and Interleukins (2 papers), Diabetes Management and Research (1 paper) and Respiratory Support and Mechanisms (1 paper). The work is most often cited by research in Infectious Diseases (2.2k citations), Neurology (1.1k citations), Clinical Psychology (517 citations), Pharmacology (144 citations) and Obstetrics and Gynecology (110 citations). Mingfeng Han has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Xiuyong Li, Wei Sun, Haiming Wei, Xiaohu Zheng, Aijun Pan, Binqing Fu, Tiantian Li, Yun Yang, Xiao‐Hua Zhang and Yonggang Zhou. Their work appears in journals such as Frontiers in Medicine, Aging, Journal of Inflammation Research, Frontiers in Pharmacology and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.